Question 1

How many shares of CERE does ProShare Advisors LLC own?

Accepted Answer

ProShare Advisors LLC previously held 0 shares of CERE (CEREVEL THERAPEUTICS HLDNG I) before exiting the position in 2024-Q3.

Question 2

What is ProShare Advisors LLC's CERE position worth?

Accepted Answer

ProShare Advisors LLC's CERE position was last reported at $0 in 2024-Q3 before the exit.

Question 3

Is ProShare Advisors LLC buying or selling CERE?

Accepted Answer

In 2024-Q3, ProShare Advisors LLC exited their CERE position entirely (-100.0% change in shares).

Question 4

When did ProShare Advisors LLC first buy CERE?

Accepted Answer

Based on available 13F filings, ProShare Advisors LLC first reported a position in CERE in 2021-Q2. They have held the position across 13 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q2	Decreased	15,422	-19.4%	$630,606	0.0%	—	0
2024-Q1	Increased	19,138	+0.2%	$808,963	0.0%	—	25
2023-Q4	New	19,097	-	$809,713	0.0%	—	34
2023-Q3	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q2	New	8,048	-	$255,846	0.0%	—	32
2023-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q4	New	7,372	-	$232,513	0.0%	—	32
2022-Q2	Exited	0	-100.0%	$0	0.0%	—	0
2022-Q1	Decreased	7,642	-14.1%	$268,000	0.0%	—	0
2021-Q4	New	8,901	-	$289,000	0.0%	—	32
2021-Q3	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	New	9,148	-	$234,000	0.0%	—	32

CERE13 quarters

CERE
13 quarters